Biden tests positive for COVID-19, has ‘very mild symptoms’

July 21, 2022July 21, 2022 Tina Marie (Ms. Cat)

By ZEKE MILLER and CHRIS MEGERIAN, Associated Press
WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 on Thursday and is experiencing “very mild symptoms,” the White House said, as new variants of the highly contagious virus are challenging the nation’s efforts to get back to normal after two and a half years of pandemic disruptions.
Biden tests positive for COVID-19, has ‘very mild symptoms’

Who will pay for Biden’s new “forever war”?

July 2, 2022July 2, 2022 Tina Marie (Ms. Cat)

This week, the United States and its NATO allies pledged to increase their troop presence in Europe seven-fold, in order to prepare for what they called “warfighting against nuclear-armed peer-competitors”–that is, war against Russia and China.
Who will pay for Biden’s new “forever war”?

Related:

Glenn Hubbard’s WSJ Op-Ed: NATO Needs More Guns and Less Butter

Hubbard is a nonresident senior fellow at the right-wing think tank, American Enterprise Institute!

DOUBLE-BOOSTED Fauci’s Covid WORSENS After Paxlovid Rebound.

June 30, 2022June 30, 2022 Tina Marie (Ms. Cat)

Fauci first tested positive after having a “scratchy throat,” he told the newspaper. After taking Paxlovid, he was “surprised and disappointed” to see he tested positive again, and he had symptoms such as a low fever, achiness, runny nose, and “mild cough.” He then called his doctor, who prescribed another 5-day course of Paxlovid, which Fauci said is relatively common among those who have a rebound.
…
Earlier this month, Pfizer, the maker of Paxlovid, announced that it would stop adding new people to a clinical trial of the drug among COVID-19 patients who have a low risk of hospitalization and death. The study failed to show that the drug reduced symptoms, hospitalizations, or deaths in a statistically significant way, Bloomberg reported.

COVID-19 Rebound After Paxlovid Treatment:

There is currently no evidence that additional treatment is needed with Paxlovid or other anti-SARS-CoV-2 therapies in cases where COVID-19 rebound is suspected.

Going against CDC guidance, huh?! Hypocrite!

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic (Fauci, Baric, Denison, DTRA & Gilead Sciences)

April 4, 2022April 4, 2022 Tina Marie (Ms. Cat)

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic

Related:

Study shows effectiveness of pill form of remdesivir to treat COVID-19 in mice (Ralph Baric & Gilead Sciences)**

Molnupiravir & Ivermectin’s Equine Connections

An emerging antiviral takes aim at COVID-19

[Molnupiravir] EIDD-2801’s story starts years before the coronavirus crisis. In 2014, Painter and his colleagues at Emory University began a project funded by the Defense Threat Reduction Agency to find an antiviral compound that could fight Venezuelan equine encephalitis virus (VEEV). During the Cold War, both the US and the Soviet Union studied VEEV as a potential biological weapon. Typically transmitted through mosquito bites, VEEV causes high fevers, headaches, and sometimes encephalitis, swelling of the brain that can be deadly.
…
In late 2019, Painter got a contract from the National Institute of Allergy and Infectious Diseases* to move EIDD-2801 into Phase I clinical trials for influenza. The plan was to file an investigational new drug application and find a partner to help with the clinical work.
…
Just as the team was contemplating its next move, word of a virus spreading in Wuhan, China, was starting to make news. One of Painter’s collaborators, UNC coronavirus expert Ralph Baric**, immediately alerted him that the new pathogen was probably a coronavirus—one that EIDD-2801 could potentially combat.
Denison*** says the research team knew a coronavirus outbreak was inevitable. “Every single one of our grants, every single one of our papers predicted that this event was going to happen that’s occurring right now,” he says. “The whole goal of our drug development was to plan for this.”

*Anthony Fauci, director of NIAID.

**Ralph Baric, patents.

***Mark Denison (Denison Lab/Vanderbilt University Medical Center & Gilead Sciences)

Rat Out Your Doctor: Biden’s Surgeon General Calls on Informants to Report Use of Generic Drugs

March 13, 2022March 13, 2022 Tina Marie (Ms. Cat)

Rat Out Your Doctor: Biden’s Surgeon General Calls on Informants to Report Use of Generic Drugs

The purpose of the RFI is described as being to help the authorities understand the effect of pandemic “misinformation” on such areas as “health decisions and outcomes, direct and indirect costs, trust in the healthcare system and providers, and healthcare worker morale and safety. It is also intended to help them ascertain its impact on “access to trusted and credible health information, particularly during a public health emergency” and on “lifesaving health decisions such as an individual’s likelihood to vaccinate, and to “prepare for and respond to future public health crises.”
The RFI, which covers a period extending from January 2020 to the present, applies to general search engines, content sharing platforms, social media platforms, e-commerce platforms, crowd-sourced platforms, and instant messaging systems, and includes “research, case studies, data sets, images, data visualizations, interviews, and personal testimonies.”

Is Putin the New Coronavirus?

March 9, 2022March 9, 2022 Tina Marie (Ms. Cat)

President Biden’s “maskless” State of the Union signifies the near-end of the COVID tyranny we have lived under for the past two years. Fortunately for Congress, the President, and the Federal Reserve, the Ukraine-Russia conflict is replacing COVID as a ready-made excuse for their failures and a justification for expanding their power.
Is Putin the New Coronavirus?